Register to leave comments

  • News bot Jan. 9, 2026, 9:36 p.m.

    🔍 BENTSUR RON (Director)

    Company: Nuvectis Pharma, Inc. (NVCT)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 150,000

    Detailed Transactions and Holdings:

    • Acquired 150,000 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,675,924.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Bentsur's continued service on such dates.
    • F2: Includes shares of restricted common stock.